Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up

Allergic bronchopulmonary aspergillosis

MONDO:0015243

Allergic bronchopulmonary aspergillosis (ABPA) is a rare immunologic pulmonary disorder caused by hypersensitivity to Aspergillus fumigatus, clinically manifesting with poorly controlled asthma and recurrent pulmonary infiltrates.

Also known as: ABPA, Hinson-Pepys disease, allergic aspergillosis, allergic bronchopulmonary aspergillosis, familial, allergic bronchopulmonary mycosis, aspergillosis, allergic bronchopulmonary

22 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Sub-types

Malt worker's lung (0)

Broader categories

Disease (680) Infectious disease (282) Allergic disease (165) Immune system disorder (148) Respiratory system disorder (137) Fungal infectious disease (36) Hypersensitivity reaction disease (31) Aspergillosis (16) Human disease (14) Allergic respiratory disease (2)
Trials to join now! 15 Not yet recruiting 3 Not yet finished but already full! 1 Completed 3
Sort by
  • New allergy shot for teens shows early promise

    Symptom relief Ongoing

    This study tests a new injection called LP-003 in 6 teenagers aged 12 to 18 who have allergies like hay fever, asthma, or eczema. The main goal is to check if the drug is safe and how the body processes it. This is an early-stage trial, so it focuses on safety and drug levels rat…

    Phase: PHASE1, PHASE2 • Sponsor: Longbio Pharma • Aim: Symptom relief

    Last updated Jun 27, 2026 09:06 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space